The Enterprise Value as of November 2024 (TTM) for Basilea Pharmaceutica AG (BPMUF) is 614.88M

According to Basilea Pharmaceutica AG’s latest financial reports and current stock price. The company's current Enterprise Value is 614.88M. This represents a change of 49.12% compared to the average of 412.34M of the last 4 quarters.

Basilea Pharmaceutica AG (BPMUF) Historical Enterprise Value (quarterly & annually)

How has BPMUF Enterprise Value performed in the past?

The mean historical Enterprise Value of Basilea Pharmaceutica AG over the last ten years is 734.90M. The current 614.88M Enterprise Value has changed 8.27% with respect to the historical average. Over the past ten years (40 quarters), BPMUF's Enterprise Value was at its highest in in the December 2014 quarter at 1.18B. The Enterprise Value was at its lowest in in the March 2024 quarter at 0.

Basilea Pharmaceutica AG (BPMUF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Basilea Pharmaceutica AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Basilea Pharmaceutica AG (BPMUF) Average Enterprise Value

How has BPMUF Enterprise Value performed in the past?

The current Enterprise Value of Basilea Pharmaceutica AG (BPMUF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Basilea Pharmaceutica AG (BPMUF) Enterprise Value vs. Peers

How is BPMUF’s Enterprise Value compared to its peers?

Basilea Pharmaceutica AG’s Enterprise Value is greater than Ocuphire Pharma, Inc. (-9671816.00), greater than Reviva Pharmaceuticals Holdings, Inc. (33.37M), greater than Protalix BioTherapeutics, Inc. (102.72M), greater than EyePoint Pharmaceuticals, Inc. (552.94M), greater than SELLAS Life Sciences Group, Inc. (61.79M), greater than ProQR Therapeutics N.V. (286.46M), less than Alnylam Pharmaceuticals, Inc. (31.79B), less than Wave Life Sciences Ltd. (1.89B), less than Blueprint Medicines Corporation (6.36B), less than Apellis Pharmaceuticals, Inc. (3.90B), less than Moderna, Inc. (0), less than CureVac N.V. (15.48B), greater than Novavax, Inc. (61.76M), less than CohBar, Inc. (1.02B), greater than Reata Pharmaceuticals, Inc. (-4477266.00), less than BioNTech SE (6.64B), less than Ginkgo Bioworks Holdings, Inc. (16.64B), greater than CRISPR Therapeutics AG (242.08M), less than null (4.09B),

Build a custom stock screener for Basilea Pharmaceutica AG (BPMUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Basilea Pharmaceutica AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Basilea Pharmaceutica AG (BPMUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Basilea Pharmaceutica AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.